Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
Data is from hand book

Data source

Reference
Reference Type:
review article or handbook
Title:
Absorption, Distribution and Metabolism of 4-(2-aminoethyl)phenol
Author:
S.D. Gangolli
Year:
1999
Bibliographic source:
Dictionary of Substances and their Effects (DOSE), 2nd edition, Volume 7-part 5, 1999

Materials and methods

Objective of study:
absorption
distribution
metabolism
Test guideline
Qualifier:
according to guideline
Guideline:
other: as below
Principles of method if other than guideline:
In vivo Absorption, Distribution and Metabolism study of 4-(2-aminoethyl)phenol in human
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
4-(2-aminoethyl)phenol
EC Number:
200-115-8
EC Name:
4-(2-aminoethyl)phenol
Cas Number:
51-67-2
Molecular formula:
C8H11NO
IUPAC Name:
4-(2-aminoethyl)phenol
Details on test material:
Name: 4-(2-Aminoethyl)phenol
SMILES:NCCc1ccc(O)cc1
InChI:1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2
Mol. formula: C8H11NO
Molecular Weight: 137.1809 g/mole
Specific details on test material used for the study:
Name: 4-(2-Aminoethyl)phenol
SMILES:NCCc1ccc(O)cc1
InChI:1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2
Mol. formula: C8H11NO
Molecular Weight: 137.1809 g/mole
Radiolabelling:
not specified

Test animals

Species:
other: Human
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
not specified
Vehicle:
not specified
Duration and frequency of treatment / exposure:
not specified
Doses / concentrations
Remarks:
no specified
No. of animals per sex per dose / concentration:
not specified
Control animals:
not specified
Positive control reference chemical:
not specified
Details on study design:
not specified
Details on dosing and sampling:
not specified
Statistics:
not specified

Results and discussion

Preliminary studies:
not specified
Main ADME resultsopen allclose all
Type:
absorption
Results:
4-(2-aminoethyl) phenol can be absorbed from the gastro-intestinal tract
Type:
distribution
Results:
4-(2-aminoethyl) phenol can penetrate most organs, including the brain. It can be deaminated by monoamine oxidase types A and B in a variety of tissues, including the wall of the gastro-intestinal tract and the central nervous system
Type:
metabolism
Results:
4-(2-aminoethyl) phenol can be conjugated, and production of tyramine-0-sulfate as a urinary metabolite

Toxicokinetic / pharmacokinetic studies

Details on absorption:
4-(2-aminoethyl) phenol can be absorbed from the gastro-intestinal tract

Metabolite characterisation studies

Metabolites identified:
yes
Remarks:
tyramine-0-sulfate

Applicant's summary and conclusion

Conclusions:
4-(2-aminoethyl)phenol is likely to exhibit low bio-accumulation potential based on study results and use.
Executive summary:

Available data pertaining to the in-vivoAbsorption, Distribution and Metabolism of the chemical 4-(2-aminoethyl)phenol suggests absorbed from the gastro-intestinal tract and distributed by penetrate in most organs, including the brain. It can be deaminated by monoamine oxidase types A and B in a variety of tissues, including the wall of the gastro-intestinal tract and the central nervous system.Metabolism of 4-(2-aminoethyl) phenolby conjugation, and production of tyramine-0-sulfate as a urinary metabolite.Thus, there is no evidence that they or their metabolites would accumulate in tissues and cause a concern for consumer safety. Also, the Use Therapeutically as the hydrochloride as a sympathomimetic agent. Hence it is concluded that 4-(2-aminoethyl)phenolis likely to exhibit low bio-accumulation potential based on study results and use.